arrow_back Trending Legislation
Share share

Extending Funding for Childhood Disease and Cancer Research

This law provides an additional $25 million annually from 2023 to 2027 for research into diseases affecting children, including cancer. The goal is to support new discoveries and therapies that can improve children's health and lives. The act emphasizes coordinating research to ensure funds are spent effectively.
Key points
Allocates $25 million per year from 2023 to 2027 for pediatric research.
Supports research into childhood cancer and other serious conditions.
Aims for better coordination of research to avoid duplicating efforts.
Requires a report on research progress and funding use within 5 years.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Gabriella Miller Kids First Research Act 2.0
Print number: HR 623
Sponsor: Rep. Wexton, Jennifer [D-VA-10]
Process start date: 2021-01-28
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-04-17
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Extending Funding for Childhood Disease and Cancer Research

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 623.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-01-28.

What are the main provisions?

Key points include:

  • Allocates $25 million per year from 2023 to 2027 for pediatric research.
  • Supports research into childhood cancer and other serious conditions.
  • Aims for better coordination of research to avoid duplicating efforts.
  • Requires a report on research progress and funding use within 5 years.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Wexton, Jennifer [D-VA-10].

What is the latest detailed status?

The latest detailed status is: The title of the measure was amended. Agreed to without objection.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

Analysis and Potential Impact of HR 623

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health